SAKURAI Hiroaki

写真a

Title

Professor

Campus Career 【 display / non-display

  • 2019.10
     
     

    University of ToyamaAcademic Assembly   Faculty of Pharmaceutical Sciences   Professor  

  • 2019.10
     
     

    University of ToyamaFaculty of Pharmacy and Pharmaceutical Sciences   Department of Pharmaceutical Sciences   Professor  

  • 2011.08
    -
    2019.09

    University of ToyamaGraduate School of Medicine and Pharmaceutical Sciences for Research   Integrative Oriental and Western Medicine   Clinical Pharmaceutical Science   Professor  

  • 2011.08
    -
    2019.09

    University of ToyamaFaculty of Pharmacy and Pharmaceutical Sciences   Department of Pharmaceutical Sciences   Professor  

Field of expertise (Grants-in-aid for Scientific Research classification) 【 display / non-display

  • Biological pharmacy

Qualification acquired 【 display / non-display

  • Pharmacist

  • Chief Person of Radiation Handling (first and second kind)

 

Papers 【 display / non-display

  • ORCID ID

    Hiroaki Sakurai

    https://orcid.org/0000-0003-0657-9570     2019

    Single Work

  • Scopus ID

    Hiroaki Sakurai

    7402869815     2019

    Single Work

  • Rational Combination Therapy for Melanoma with Dinaciclib by Targeting BAK-Dependent Cell Death.

    Xu X, Eshima S, Kato S, Fisher DE, Sakurai H, Hayakawa Y, Yokoyama S

    Molecular cancer therapeutics   19 ( 2 ) 627 - 636   2020.02

    Joint Work

    DOI PubMed

  • The serum amyloid A3 promoter-driven luciferase reporter mice is a valuable tool to image early renal fibrosis development and shows the therapeutic effect of glucosyl-hesperidin treatment.

    Kumrungsee T, Kariya T, Hashimoto K, Koyano T, Yazawa N, Hashimoto T, Sanada Y, Matsuyama M, Sotomaru Y, Sakurai H, van de Loo FAJ, Yanaka N

    Scientific reports   9 ( 1 ) 14101   2019.10

    Joint Work

    DOI PubMed

  • Negative feedback regulation of ErbB4 tyrosine kinase activity by ERK-mediated non-canonical phosphorylation.

    Haryuni RD, Watabe S, Yamaguchi A, Fukushi Y, Tanaka T, Kawasaki Y, Zhou Y, Yokoyama S, Sakurai H

    Biochemical and biophysical research communications   514 ( 2 ) 456 - 461   2019.06

    Joint Work

    DOI PubMed

display all >>

Review Papers 【 display / non-display

  • Targeting of TAK1 in inflammatory disorders and cancer

    Sakurai H.

    Trends Pharmacol. Sci. ( Cell Press )  30   522 - 530   2012.10

    Introduction and explanation (scientific journal)   Single Work

Grant-in-Aid for Scientific Research 【 display / non-display

  • Grant-in-Aid for Scientific Research(B)

    Project Year: 2019.04  -  2022.03 

  • Grant-in-Aid for Scientific Research(B)

    Project Year: 2016.04  -  2019.03 

  • Grant-in-Aid for challenging Exploratory Research

    Project Year: 2016.04  -  2018.03 

  • Grant-in-Aid for challenging Exploratory Research

    Project Year: 2014.04  -  2016.03 

  • Grant-in-Aid for Scientific Research(C)

    Project Year: 2011.04  -  2015.03